S

Sandoz Group AG
SIX:SDZ

Watchlist Manager
Sandoz Group AG
SIX:SDZ
Watchlist
Price: 40.6 CHF 2.4% Market Closed
Market Cap: 17.9B CHF
Have any thoughts about
Sandoz Group AG?
Write Note

Intrinsic Value

The intrinsic value of one SDZ stock under the Base Case scenario is 43.65 CHF. Compared to the current market price of 40.6 CHF, Sandoz Group AG is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SDZ Intrinsic Value
43.65 CHF
Undervaluation 7%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Sandoz Group AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SDZ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SDZ?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Sandoz Group AG

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Sandoz Group AG

Provide an overview of the primary business activities
of Sandoz Group AG.

What unique competitive advantages
does Sandoz Group AG hold over its rivals?

What risks and challenges
does Sandoz Group AG face in the near future?

Has there been any significant insider trading activity
in Sandoz Group AG recently?

Summarize the latest earnings call
of Sandoz Group AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sandoz Group AG.

Provide P/S
for Sandoz Group AG.

Provide P/E
for Sandoz Group AG.

Provide P/OCF
for Sandoz Group AG.

Provide P/FCFE
for Sandoz Group AG.

Provide P/B
for Sandoz Group AG.

Provide EV/S
for Sandoz Group AG.

Provide EV/GP
for Sandoz Group AG.

Provide EV/EBITDA
for Sandoz Group AG.

Provide EV/EBIT
for Sandoz Group AG.

Provide EV/OCF
for Sandoz Group AG.

Provide EV/FCFF
for Sandoz Group AG.

Provide EV/IC
for Sandoz Group AG.

Show me price targets
for Sandoz Group AG made by professional analysts.

What are the Revenue projections
for Sandoz Group AG?

How accurate were the past Revenue estimates
for Sandoz Group AG?

What are the Net Income projections
for Sandoz Group AG?

How accurate were the past Net Income estimates
for Sandoz Group AG?

What are the EPS projections
for Sandoz Group AG?

How accurate were the past EPS estimates
for Sandoz Group AG?

What are the EBIT projections
for Sandoz Group AG?

How accurate were the past EBIT estimates
for Sandoz Group AG?

Compare the revenue forecasts
for Sandoz Group AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sandoz Group AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sandoz Group AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sandoz Group AG compared to its peers.

Compare the P/E ratios
of Sandoz Group AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Sandoz Group AG with its peers.

Analyze the financial leverage
of Sandoz Group AG compared to its main competitors.

Show all profitability ratios
for Sandoz Group AG.

Provide ROE
for Sandoz Group AG.

Provide ROA
for Sandoz Group AG.

Provide ROIC
for Sandoz Group AG.

Provide ROCE
for Sandoz Group AG.

Provide Gross Margin
for Sandoz Group AG.

Provide Operating Margin
for Sandoz Group AG.

Provide Net Margin
for Sandoz Group AG.

Provide FCF Margin
for Sandoz Group AG.

Show all solvency ratios
for Sandoz Group AG.

Provide D/E Ratio
for Sandoz Group AG.

Provide D/A Ratio
for Sandoz Group AG.

Provide Interest Coverage Ratio
for Sandoz Group AG.

Provide Altman Z-Score Ratio
for Sandoz Group AG.

Provide Quick Ratio
for Sandoz Group AG.

Provide Current Ratio
for Sandoz Group AG.

Provide Cash Ratio
for Sandoz Group AG.

What is the historical Revenue growth
over the last 5 years for Sandoz Group AG?

What is the historical Net Income growth
over the last 5 years for Sandoz Group AG?

What is the current Free Cash Flow
of Sandoz Group AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sandoz Group AG.

Business Breakdown

Sandoz Group AG, a global leader in generics and biosimilars, operates as a subsidiary of the Swiss pharmaceutical giant Novartis. Established in 1886, Sandoz has a storied history rooted in innovation and a commitment to providing high-quality and affordable medications. The company's mission focuses on improving patient access to essential treatments, making it a critical player in the healthcare landscape. With a diverse portfolio of over 1,000 generic pharmaceuticals and a growing range of biosimilars, Sandoz strategically positions itself to meet the increasing global demand for cost-effective alternatives to brand-name drugs. Its robust research and development efforts ensure that Sand...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Sandoz Group AG

Balance Sheet Decomposition
Sandoz Group AG

Balance Sheet Decomposition is not available for
Sandoz Group AG
Efficiency

Earnings Waterfall
Sandoz Group AG

Revenue
10B USD
Cost of Revenue
-5.3B USD
Gross Profit
4.7B USD
Operating Expenses
-3.4B USD
Operating Income
1.3B USD
Other Expenses
-1.2B USD
Net Income
77m USD

Free Cash Flow Analysis
Sandoz Group AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Sandoz concluded an exceptional 2023, with sales growth surpassing expectations and core EBITDA meeting predictions. Successful spin-off and strategic movements, including key acquisitions and product launches, positioned the company strongly going into 2024. Biosimilar sales rose to 23% of total sales, driving up margins. Full year sales reached $9.6 billion, marking a 7% rise. However, core EBITDA margin saw a 3.2 percentage point dip to 18.1%. The company maintains a robust European presence and has growing momentum in North America and International markets.

What is Earnings Call?
Fundamental Scores

SDZ Profitability Score
Profitability Due Diligence

Sandoz Group AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
54/100
Profitability
Score

Sandoz Group AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

SDZ Solvency Score
Solvency Due Diligence

Sandoz Group AG's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Interest Coverage
Positive Net Debt
45/100
Solvency
Score

Sandoz Group AG's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SDZ Price Targets Summary
Sandoz Group AG

Wall Street analysts forecast SDZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SDZ is 42.33 CHF with a low forecast of 35.35 CHF and a high forecast of 52.5 CHF.

Lowest
Price Target
35.35 CHF
13% Downside
Average
Price Target
42.33 CHF
4% Upside
Highest
Price Target
52.5 CHF
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SDZ?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SDZ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SDZ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

SDZ News

Other Videos

Profile

Sandoz Group AG

Country

Switzerland

Industry

Pharmaceuticals

Market Cap

17.5B CHF

Dividend Yield

1.11%

Description

Sandoz Group AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Rotkreuz, Zug. The company went IPO on 2023-10-04. Sandoz Group AG is a Switzerland based company working in the healthcare technology field, the Company does this by operating in two segments, generics and biosimilar. Generic refers to drugs that is structurally equivalent to an original drug whose patent expired. Biosimilar refers to drugs, unlike generics that are equivalent, are slightly different from other approved reference biologics but has no clinically significant differences. The firm interacts in these fields, either directly or indirectly, by the buying and selling of intellectual property and other assets relating to generics and biosimilar drugs. The geographic scope of these investment can fall either domestically or internationally.

Contact

ZUG
Rotkreuz
Suurstoffi 14

IPO

2023-10-04

Employees

-

Officers

Chief Executive Officer
Mr. Richard Saynor
Chief Financial Officer
Mr. Remco J. Steenbergen
Chief Technology Officer
Mr. Asaf Gal
Chief Scientific Officer
Ms. Claire D'Abreu-Hayling
Head Global Investor Relations
Ms. Karen M. King
General Counsel & Chief Compliance Officer
Ms. Ingrid Sollerer
Show More
Chief People Officer
Ms. Tripti Jha
President of International
Mr. Francisco Ballester
Chief Commercial Officer
Mr. Pierre Bourdage
Chief Manufacturing & Supply Officer
Dr. Glenn A. Gerecke Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one SDZ stock?

The intrinsic value of one SDZ stock under the Base Case scenario is 43.65 CHF.

Is SDZ stock undervalued or overvalued?

Compared to the current market price of 40.6 CHF, Sandoz Group AG is Undervalued by 7%.

Back to Top